Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Fibrosis 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Mucositis 2Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pentoxifylline, Cisplatin, Nephrotoxixcity 1Pancreatitis, Alcoholic 1Pancreatitis 1Pain 1Osteoradionecrosis 1Non-small Cell Lung Cancers 1Neuritis 1Neoplasms 1Lymphedema 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Hodgkin Disease 1Erectile Dysfunction 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Capsular Contractures 1Breast Cancer Female 1Brain Neoplasms 1

Interventions

Sildenafil Citrate 8Tadalafil 2Surveys and Questionnaires 2Alprostadil 2udenafil 1trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1mirabegron 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alpha-Tocopherol 1alectinib 1Vitamin E 1Tamoxifen 1Surgical Instruments 1Saline Solution 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Pentoxifylline 1Pemetrexed 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Erectile Dysfunction × Pentoxifylline × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡